Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

129 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Durvalumab therapy following chemoradiation compared with a historical cohort treated with chemoradiation alone in patients with stage III non-small cell lung cancer: A real-world multicentre study.
Desilets A, Blanc-Durand F, Lau S, Hakozaki T, Kitadai R, Malo J, Belkaid W, Richard C, Messaoudene M, Cvetkovic L, Kazandjian S, Tehfe M, Florescu M, Jao K, Daaboul N, Owen S, Shieh B, Agulnik J, Cohen V, Charbonneau C, Marcoux N, Blais N, Leighl NB, Bradbury PA, Liu G, Shepherd FA, Bahig H, Routy B, Sacher A, Elkrief A. Desilets A, et al. Among authors: shieh b. Eur J Cancer. 2021 Jan;142:83-91. doi: 10.1016/j.ejca.2020.10.008. Epub 2020 Nov 24. Eur J Cancer. 2021. PMID: 33242835
Neoadjuvant Prehabilitation Therapy for Locally Advanced Non-Small-Cell Lung Cancer: Optimizing Outcomes Throughout the Trajectory of Care.
Schmid S, Minnella EM, Pilon Y, Rokah M, Rayes R, Najmeh S, Cools-Lartigue J, Ferri L, Mulder D, Sirois C, Owen S, Shieh B, Ofiara L, Wong A, Sud S, Baldini G, Carli F, Spicer J. Schmid S, et al. Among authors: shieh b. Clin Lung Cancer. 2022 Nov;23(7):593-599. doi: 10.1016/j.cllc.2022.05.004. Epub 2022 May 11. Clin Lung Cancer. 2022. PMID: 35705449
Transitioning to Neoadjuvant Therapy for Resectable Non-Small Cell Lung Cancer: Trends and Surgical Outcomes in a Regionalized Pulmonary Oncology Network.
Pilon Y, Rokah M, Seitlinger J, Sepesi B, Rayes RF, Cools-Lartigue J, Najmeh S, Sirois C, Mulder D, Ferri L, Abdulkarim B, Ezer N, Fraser R, Camilleri-Broët S, Fiset PO, Wong A, Sud S, Langleben A, Agulnik J, Pepe C, Shieh B, Hirsh V, Ofiara L, Owen S, Spicer JD. Pilon Y, et al. Among authors: shieh b. Clin Lung Cancer. 2024 May;25(3):e133-e144.e4. doi: 10.1016/j.cllc.2023.12.005. Epub 2023 Dec 19. Clin Lung Cancer. 2024. PMID: 38378398
A Phase II Study of Neoadjuvant Opnurasib KRAS G12C Inhibitor in Patients With Surgically Resectable Non-Small Cell Lung Cancer (CCTG IND.242A): A Substudy of the IND.242 Platform Master Protocol.
Spicer J, Blais N, Owen S, Robinson AG, Chu Q, Labbe C, Shieh B, Brown-Walker P, Sederias J, Jensen K, Farago AF, Tsao MS, Cottrell TR, Kidane B, Laurie S, Juergens R, Bradbury PA, Tu W, Gaudreau PO. Spicer J, et al. Among authors: shieh b. Clin Lung Cancer. 2024 Sep 20:S1525-7304(24)00198-0. doi: 10.1016/j.cllc.2024.09.003. Online ahead of print. Clin Lung Cancer. 2024. PMID: 39394034 Free article.
Routine Clinically Detected Increased ROS1 Transcripts Are Related With ROS1 Expression by Immunohistochemistry and Associated With EGFR Mutations in Lung Adenocarcinoma.
Grenier K, Rivière JB, Bencheikh BOA, Corredor ALG, Shieh BC, Wang H, Fiset PO, Camilleri-Broët S. Grenier K, et al. Among authors: shieh bc. JTO Clin Res Rep. 2023 May 24;4(7):100530. doi: 10.1016/j.jtocrr.2023.100530. eCollection 2023 Jul. JTO Clin Res Rep. 2023. PMID: 37415647 Free PMC article.
Initial Clinical Experience With a Flexible Peripheral 21-G Needle Device.
Tremblay A, Myers R, Beaudoin EL, Bonifazi M, Delage A, Fortin M, Hergott CA, MacEachern PR, Shaipanich T, Shieh B, Gasparini S, Lam S. Tremblay A, et al. Among authors: shieh b. J Bronchology Interv Pulmonol. 2018 Oct;25(4):346-348. doi: 10.1097/LBR.0000000000000505. J Bronchology Interv Pulmonol. 2018. PMID: 29664761
Datopotamab Deruxtecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non-Small Cell Lung Cancer: The Randomized, Open-Label Phase III TROPION-Lung01 Study.
Ahn MJ, Tanaka K, Paz-Ares L, Cornelissen R, Girard N, Pons-Tostivint E, Vicente Baz D, Sugawara S, Cobo M, Pérol M, Mascaux C, Poddubskaya E, Kitazono S, Hayashi H, Hong MH, Felip E, Hall R, Juan-Vidal O, Brungs D, Lu S, Garassino M, Chargualaf M, Zhang Y, Howarth P, Uema D, Lisberg A, Sands J; TROPION-Lung01 Trial Investigators. Ahn MJ, et al. J Clin Oncol. 2024 Sep 9:JCO2401544. doi: 10.1200/JCO-24-01544. Online ahead of print. J Clin Oncol. 2024. PMID: 39250535
129 results